Amit Choudhary
Summary
Accomplished in spearheading strategic initiatives at Sekhmet Pharmaventures, I've driven market expansion and forged key partnerships, enhancing global presence and revenue streams. Expert in business intelligence and cross-functional collaboration, my work has significantly contributed to portfolio optimization and achieving a notable EBITA increase, showcasing a profound impact on business growth and operational excellence.
Overview
6
6
years of professional experience
Work History
Manager – Business Development
Sekhmet Pharmaventures
12.2020 - Current
- Led business development efforts for new market penetration in APAC-North Asia, CIS, GCC, and Africa regions.
- Expanded Sekhmet's global presence into new regions, including China, Japan, and Korea.
- Established a revenue stream surpassing USD 10 million across APAC-NEA, with over 10 DMFs under registration.
- Advised the CCO to finalize and approve RFPs/RFQs for the global market.
- Determined business development opportunities and implemented effective strategy for client acquisition.
- Responsible for evaluating and finalizing the in-licensing and out-licensing opportunities.
Manager – BI & Portfolio/Strategy
Sekhmet Pharmaventures
- Introduced systems and processes to enable a formal review mechanism on commercial parameters.
- Secured Board of Directors' approval for on addition of technological capabilities in fermentation and peptides.
- Presented and secured the Board of Directors' approval for the First Portfolio Strategy for the Sekhmet Group.
- Assisted the CEO in building a commercial strategy for Sekhmet and defined a clear plan of action.
- Formulated detailed multi-year forecasts (FY24-FY30) for various business segments.
- Spearheaded portfolio selection and cost optimization initiatives for global markets.
- Implemented multiple management review processes such as pricing policy, NPI review, and S&OP process.
MD’s Office – Strategy & Portfolio
Optimus Drugs (Subsidiary of Sekhmet)
- Spearheaded acquisition initiatives from Optimus (acted as SPOC for Business and Technical Due Diligence).
- Successfully managed PLI 2.0, which led to additional EBITA of 20 cr per annum (10% of total).
- Managed worldwide portfolio selection in the API and FDF verticals.
- Oversaw project management for new product development at R&D centers with a team of two.
- Facilitated preparation of strategic plan ensuring alignment with business objectives.
- Coordinated all aspects of developing and launching Molnupiravir with emphasis on media and branding.
Management Intern
HDFC Bank
05.2019 - 06.2019
Education
MBA -
IIM Jammu
Jammu, India01-2020
B.Com - Finance
Subodh College
Jaipur, India01-2017
Skills
- Business development
- Cross-functional collaboration
- Mergers and acquisitions
- Business intelligence and analysis
- Strategic planning
- Key decision making
- Go-to-market strategy
- Pricing strategy
- Portfolio management
- Program management
- Performance evaluation
Languages
Hindi
First Language
English
Proficient (C2)
C2
Timeline
Manager – Business Development
Sekhmet Pharmaventures
12.2020 - Current
Management Intern
HDFC Bank
05.2019 - 06.2019
Manager – BI & Portfolio/Strategy
Sekhmet Pharmaventures
MD’s Office – Strategy & Portfolio
Optimus Drugs (Subsidiary of Sekhmet)
MBA -
IIM Jammu
B.Com - Finance
Subodh College
Similar Profiles
P.RAJESH PANDIP.RAJESH PANDI
Microbiology Manager at Sekhmet Pharmaventures-Anjan Drug Private LimitedMicrobiology Manager at Sekhmet Pharmaventures-Anjan Drug Private Limited
S PRADEEPS PRADEEP
Vice President – Sales & BD at Sekhmet Pharma Ventures Pvt LtdVice President – Sales & BD at Sekhmet Pharma Ventures Pvt Ltd
Yaroslav TryhubaYaroslav Tryhuba
Сhief Mechanic of the Company at SEKHMET SRLСhief Mechanic of the Company at SEKHMET SRL